Axogen (AXGN) EBIT Growth (1y) (2011 - 2026)
Axogen (AXGN) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | 20.97% |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | -18.12% |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 90.95% |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | 74.18% |
| 10 | Axogen | 2.11 Bn | 2.00 Bn | 46.19 Mn | -70.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70.50% |
| Dec 31, 2025 | -584.48% |
| Sep 30, 2025 | 705.06% |
| Jun 30, 2025 | 490.65% |
| Mar 31, 2025 | 63.57% |
| Dec 31, 2024 | 163.15% |
| Sep 30, 2024 | 92.15% |
| Jun 30, 2024 | 93.80% |
| Mar 31, 2024 | 37.88% |
| Dec 31, 2023 | 43.05% |
| Sep 30, 2023 | 17.10% |
| Jun 30, 2023 | 12.90% |
| Mar 31, 2023 | 35.15% |
| Dec 31, 2022 | -4.76% |
| Sep 30, 2022 | 27.42% |
| Jun 30, 2022 | -10.76% |
| Mar 31, 2022 | -81.99% |
| Dec 31, 2021 | 0.39% |
| Sep 30, 2021 | -540.10% |
| Jun 30, 2021 | 13.33% |